Biodexa Pharmaceuticals Plc（BDRX）適時開示・決算発表
| 提出日 | 様式 | 項目 | 原文 |
|---|---|---|---|
| 2026-07-29 | 6-K | — | SEC |
| 2026-07-09 | 6-K | — | SEC |
| 2026-06-30 | 6-K | FORM 6-K | SEC |
| 2026-06-30 | 6-K | — | SEC |
| 2026-06-17 | 6-K | — | SEC |
| 2026-05-14 | 6-K | — | SEC |
| 2026-03-27 | 6-K | FORM 6-K | SEC |
| 2026-03-18 | 6-K | — | SEC |
| 2026-02-04 | 6-K | — | SEC |
| 2026-01-06 | 6-K | — | SEC |
| 2026-01-05 | 6-K | FORM 6-K | SEC |
| 2025-12-18 | 6-K | — | SEC |
| 2025-11-03 | 6-K | — | SEC |
| 2025-09-12 | 6-K | — | SEC |
| 2025-08-18 | 6-K | FORM 6-K | SEC |
| 2025-07-31 | 6-K | FORM 6-K | SEC |
| 2025-07-15 | 6-K | — | SEC |
| 2025-06-27 | 6-K | — | SEC |
| 2025-06-13 | 6-K | — | SEC |
| 2025-06-11 | 6-K | FORM 6-K | SEC |
| 2025-06-04 | 6-K | FORM 6-K | SEC |
| 2025-05-30 | 6-K | FORM 6-K | SEC |
| 2025-05-23 | 6-K | — | SEC |
| 2025-05-22 | 6-K | FORM 6-K | SEC |
| 2025-05-22 | 6-K | — | SEC |
| 2025-05-15 | 6-K | — | SEC |
| 2025-05-12 | 6-K | FORM 6-K | SEC |
| 2025-05-02 | 6-K | — | SEC |
| 2025-04-17 | 6-K | FORM 6-K | SEC |
| 2025-04-11 | 6-K | — | SEC |
| 2025-03-10 | 6-K | FORM 6-K | SEC |
| 2025-03-06 | 6-K | FORM 6-K | SEC |
| 2025-02-24 | 6-K | FORM 6-K | SEC |
| 2025-02-13 | 6-K | FORM 6-K | SEC |
| 2025-02-10 | 6-K | FORM 6-K | SEC |
| 2025-01-22 | 6-K | FORM 6-K | SEC |
| 2025-01-17 | 6-K | — | SEC |
| 2024-12-27 | 6-K | — | SEC |
| 2024-12-04 | 6-K | — | SEC |
| 2024-11-12 | 6-K | — | SEC |
| 2024-11-07 | 6-K | FORM 6-K | SEC |
| 2024-11-01 | 6-K | — | SEC |
| 2024-10-15 | 6-K | — | SEC |
| 2024-10-04 | 6-K | FORM 6-K | SEC |
| 2024-09-26 | 6-K | — | SEC |
| 2024-09-19 | 6-K | FORM 6-K | SEC |
| 2024-09-16 | 6-K | FORM 6-K | SEC |
| 2024-08-30 | 6-K | — | SEC |
| 2024-07-23 | 6-K | — | SEC |
| 2024-07-19 | 6-K | — | SEC |
| 2024-07-16 | 6-K | FORM 6-K | SEC |
| 2024-07-05 | 6-K | — | SEC |
| 2024-07-02 | 6-K | FORM 6-K | SEC |
| 2024-06-24 | 6-K | FORM 6-K | SEC |
| 2024-06-13 | 6-K | FORM 6-K | SEC |
| 2024-05-28 | 6-K | — | SEC |
| 2024-05-22 | 6-K | — | SEC |
| 2024-05-21 | 6-K | FORM 6-K | SEC |
| 2024-05-15 | 6-K | FORM 6-K | SEC |
| 2024-05-15 | 6-K | — | SEC |
出典は SEC EDGAR の 8-K／6-K。8-K は米国内企業の臨時報告（Item 2.02 が決算発表）、6-K は外国企業（ADR 含む）の対応様式です。当サイトはリンクの整理のみ行い、原文はすべて sec.gov にあります。